Gut Microbiome alterations in response to TACE in patients with HCC

This study was to investigate the differentiated gut microbiota compositions among healthy individuals, patients with hepatocellular carcinoma (HCC), and patients undergoing transarterial chemoembolization (TACE) treatment, and then unveiled the contribution of gut microbiota to influence the clinical outcome of TACE treatment.